MRPL15作为LUAD恶性扩散中的关键基因
ZhuoCai Wang1, YunFeng Qian1, XuWen Lai1
1Department of Pathology, General Hospital of Southern Theater Command,People's Liberation Army of China, No.111 Liuhua Road, Guangzhou, 510000, People's Republic of China.
Biochemical genetics
|July 30, 2025
概括
线粒体核糖体蛋白L15 (MRPL15) 促进肺腺癌 (LUAD) 细胞的增殖. 高MRPL15表达与瘤生长的增加相关,这表明MRPL15是LUAD的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 肺腺癌 (LUAD) 是一种主要的癌症类型,检测率越来越高.
- 线粒体核糖体蛋白L15 (MRPL15) 与各种癌症有关,但其在LUAD中的作用尚不清楚.
研究的目的:
- 为了研究MRPL15在LUAD组织中的表达.
- 为了确定MRPL15与LUAD中的Ki-67 (MKI67) 扩散标志物之间的相关性.
- 为了阐明MRPL15对LUAD细胞增殖的影响.
主要方法:
- 在LUAD和相邻组织中量化MRPL15表达.
- 分析了MRPL15和MKI67表达之间的相关性.
- 在LUAD细胞中利用过度基因表达和淘汰技术来评估MRPL15的功能作用.
主要成果:
- 与相邻组织相比,MRPL15在LUAD组织中显著上调.
- MRPL15表达与MKI67表达呈现出正相关性.
- 过度表达MRPL15增强了LUAD细胞的增殖,而其下调抑制了增殖.
结论:
- MRPL15促进肺腺癌细胞的增殖.
- MRPL15代表了LUAD的潜在诊断标记物和治疗点.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
The Ras Gene
6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.4K


